<![CDATA[Do Venetoclax Dose Modifications Compromise AML Outcomes?]]>

Reassessment of the Risk of Hemolytic Syndrome in Patients With Chronic Lymphocytic Leukemia Treated With a Regimen Containing Venetoclax

Conditions : Chronic Lymphoid Leukemia Interventions : Procedure: Cervical, Thoracic, Abdominal, and Pelvic CT Scan Sponsors : Private Hospi

Katelyn Daniels։ Final Results of Venetoclax Combination Therapy in Relapsed or Refractory AML

Katelyn Daniels, Physician Scientist Instructor at St. Jude Children’s Research Hospital, shared a post on LinkedIn: “Excited to share our l

Lisaftoclax Plus Azacitidine Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients at High Risk of Relapse

Conditions : Acute Myeloid Leukemia (AML); Maintenance Treatment; Hematopoetic Stem Cell Transplantation Interventions : Drug: Lisaftoclax P

Model-Informed Precision Dosing on Cyclosporine Therapy in Hematopoietic Stem Cell Transplant Recipients

Conditions : Bone Marrow Transplantation; AML Sponsors : Yasmin medhat munir Mohamed Not yet recruiting

Anixa Biosciences Aktie: Höchste Lira-cel-Dosis erreicht

Ein Meilenstein in der Krebsforschung: Anixa Biosciences hat den fünften Patienten in die höchste Dosiskohorte seiner CAR-T-Zelltherapie auf

<![CDATA[FDA Approves Ennumo, Pegfilgrastim Biosimilar Referencing Neulasta, for Febrile Neutropenia and Radiation Exposure]]>